A comprehensive view of pumps/syringes/infusion supplies. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Insulet releases 2021 sustainability report; highlights include 100% fulfillment of customer orders via dual and local sourcing while in Europe, UK, Canada, Insulet diverted over 135 metric tons of Omnipod Pods from landfills via product takeback programs
Published: May 13, 2022 by Insulet Corp.
Stevanato named exclusive manufacturer of Owen Mumford’s Aidaptus two-step, single-use auto-injector that automatically adapts to fill volume; device joins Stevanato’s portfolio of pen injector, auto-injector, inhaler, wearable delivery system
Published: May 11, 2022 by FiercePharma
Tandem Diabetes Care Q1 net loss widens to US$14.7M from US$5.0M a year ago, with sales up 25% year-over-year to US$175.9M; FDA clears t:slim X2 insulin pump to bolus with t:connect mobile app, with global pump shipments growing 11% to 28,095 pumps
Published: May 10, 2022 by Tandem Diabetes Care, Inc.
Insulet reports Q1 net income of US$27.8M from US$0.0M a year ago, with revenue up 17.1% year-over-year at US$295.4M; US revenue of Omnipod 5 automated insulin delivery system up 21.5% after limited launch in country, with full market release this year
Published: May 09, 2022 by Insulet Corp.
Insulet names Jim Hollingshead, Ph.D. as President, CEO, to succeed Shacey Petrovic, who is stepping down from the position on June 1; Dr. Hollingshead currently serves as President of Sleep and Respiratory Care at ResMed, Inc.
Published: May 09, 2022 by Insulet Corp.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count